Ganadexil Enrofloxacina 5%, 50 mg/ml süstelahus
Ganadexil Enrofloxacina 5%, 50 mg/ml süstelahus
Authorised
- Enrofloxacin
Product identification
Medicine name:
Ganadexil Enrofloxacina 5%, 50 mg/ml süstelahus
Active substance:
- Enrofloxacin
Target species:
-
Cattle (calf)
-
Pig
-
Dog
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Enrofloxacin50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Cattle (calf)
-
Meat and offal5day
-
-
-
Intramuscular use
-
Pig
-
Meat and offal13day
-
-
-
Subcutaneous use
-
Cattle (calf)
-
Meat and offal12day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Available in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Industrial Veterinaria S.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1291
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 13/01/2022